Dai-Dan Co., Ltd.
Stock Price Chart
2026/06/11 UpdatedPrice Trend
2026/06/11 UpdatedPrice & Trading Details
2026/06/11 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/06/01Earnings Calendar
Updated 2026/06/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2013/02/06 | ¥1.71 | ¥1.15 | -32.6% |
| 2012/08/08 | ¥2.41 | ¥-3.19 | -232.1% |
| 2012/05/08 | ¥7.12 | ¥11.16 | +56.8% |
| 2012/02/08 | ¥1.83 | ¥-2.40 | -231.2% |
Shareholder Composition
Updated 2026/06/01Dividend History
Updated 2026/05/31| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥56 | -12.9% |
| 2025 | ¥64 | +93.0% |
| 2024 | ¥33 | +81.8% |
| 2023 | ¥18 | +22.2% |
| 2022 | ¥15 | - |
Financial Performance
2026/05/31 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥162,929M | ¥185,961M | ¥197,431M | ¥262,732M |
| Gross Profit | ¥20,723M | ¥22,624M | ¥26,218M | ¥41,350M |
| Operating Income | ¥7,585M | ¥8,429M | ¥10,878M | ¥23,038M |
| Pretax Income | ¥8,410M | ¥9,900M | ¥13,348M | ¥24,203M |
| Net Income | ¥5,778M | ¥6,626M | ¥9,087M | ¥17,443M |
| EPS | ¥45.03 | ¥51.59 | ¥70.70 | ¥135.61 |
| Operating Margin | 4.66% | 4.53% | 5.51% | 8.77% |
| Balance Sheet | ||||
| Total Assets | ¥139,099M | ¥148,544M | ¥160,553M | ¥215,309M |
| Total Equity | ¥77,080M | ¥82,241M | ¥93,754M | ¥107,018M |
| Total Liabilities | ¥62,019M | ¥66,303M | ¥66,799M | ¥108,291M |
| Cash | ¥16,065M | ¥25,379M | ¥22,696M | ¥51,761M |
| Interest-bearing Debt | ¥3,904M | ¥3,621M | ¥3,157M | ¥23,602M |
| Equity Ratio | 55.41% | 55.36% | 58.39% | 49.70% |
| D/E Ratio | 0.05 | 0.04 | 0.03 | 0.22 |
| Cash Flow | ||||
| Operating CF | -¥11,718M | ¥15,941M | ¥596M | ¥12,402M |
| Investing CF | -¥873M | -¥4,729M | -¥603M | -¥832M |
| Financing CF | -¥3,214M | -¥2,218M | -¥2,829M | ¥16,044M |
| Free CF | -¥12,939M | ¥14,132M | -¥1,030M | ¥12,060M |
| Efficiency | ||||
| ROE | 7.50% | 8.06% | 9.69% | 16.30% |
| ROA | 4.15% | 4.46% | 5.66% | 8.10% |
Latest IR Information
-
Notice of Dividend (Increase in Dividend)
Daiden announced an increase in the year-end dividend for fiscal year ending March 2026 to 56 yen per share, with an expected total annual dividend of 250 yen after the stock split.
Read more -
【Daidan】 Announcement of Executive Personnel Changes | June 26, 2026
Daidan Corporation has decided on executive personnel changes ahead of the June 26, 2026 shareholders' meeting, announcing new and reappointed director candidates. Masatoshi Nakazawa is scheduled to be appointed as a new director.
Read more -
Fiscal Year Ending March 2026 Financial Summary
Completed construction revenue of 256,228 million yen (YoY -2.5%), Operating profit of 34,479 million yen (up 49.7% YoY), Order backlog of 353,102 million yen (up 25.5% YoY), End-of-term construction backlog of 355,273 million yen (up 37.5% YoY)
Read more -
【Daidan】2026 Financial Results｜Revenue of 256.2 billion yen, Net profit of 26.7 billion yen achieved
Daidan achieved sales of 256.2 billion yen, operating income of 34.4 billion yen, and net income attributable to owners of parent of 26.7 billion yen for the fiscal year ending March 2026. While sales decreased by 2.5% compared to the...
Read more -
Notice Regarding Revision of Earnings Guidance and Dividend Forecast for the Fiscal Year Ending March 2026 (Dividend Increase)
The consolidated operating income for the fiscal year ending March 2026 has been revised upward from JPY 32,000 million to JPY 34,000 million, a 6.3% increase. Net income attributable to owners of the parent has been revised upward from JPY...
Read more
Latest News (5 items)
-
Average Analyst Rating: strong_buy
Average Target Price: ¥3,600
Rating Score: 1.00 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Dai-Dan Co., Ltd. engages in the design, supervision, and construction of electrical, air conditioning, water hygiene, and firefighting facilities works and machinery in Japan. The company offers Hot Cure, a hospital room for immunocompromised patients; All-in-one CP unit, a cell culture processing facility; air conditioning system for hybrid operating room; MonoBooker, a system which makes the location of temporary equipment visible; brightness design solutions; CV4D, a Construction Visualizer 4D for field survey support; artificial intelligence solutions; REMOVIS, a building monitoring and management solutions; ZEB, which reduces energy consumption in buildings; and Enefice Kyushu, Enefice Shikoku, and Enefice Hokkaido buildings. It also provides iLac system, a breeding rack for experimental animals; Air Barrier Booth, a cross-contamination prevention system; Karatto Operation, air-conditioning system for operating rooms; air purification and negative pressure unit; sputum collection booth; Lami Flowrack system; and Barrier Smart, a room pressure control system. In addition, the company offers WIT WET, vaporization type humidification system; air filter regeneration; airflow analysis solutions; quick covers; lightweight reinforced ducts; heat storage tanks; Virtual Duct Clean Room system; FlowSmart technology; Cushion Ducky, an anti-corrosion technology; and anticorrosion diagnostic technology. Dai-Dan Co., Ltd. was founded in 1903 and is headquartered in Osaka, Japan.
